Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

about

Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.

Item

http://www.wikidata.org/entity/Q36294778

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@ast

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@en

type

Item

label

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@ast

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@en

prefLabel

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@ast

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@en

P1476

Synergistic Efficacy from Gene ...... onist in Murine Pompe Disease.

@en

P2093

Andrew Bird

http://www.w3.org/2001/XMLSchema#string

Dwight Koeberl

http://www.w3.org/2001/XMLSchema#string

Songtao Li

http://www.w3.org/2001/XMLSchema#string

P2860

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

The emerging phenotype of long-term survivors with infantile Pompe disease.

Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease.

Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cells.

Mapping the T helper cell response to acid α-glucosidase in Pompe mice

Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII

The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: lessons learned from infantile Pompe disease.

Algorithm for the early diagnosis and treatment of patients with cross reactive immunologic material-negative classic infantile pompe disease: a step towards improving the efficacy of ERT.

Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.

P304

743-750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2015.033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sung Ok Han

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26417913

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

4651047

http://www.w3.org/2001/XMLSchema#string